DCLK3 and neoplasm: Interestingly, recent data describing new MGL functions demonstrate that the tolerogenic phenotype in MGL+ DCs induced by the interaction between this CLR and its tumour-associated glycan ligands is associated with a metabolic quiescent phenotype in DCs that is characterised by a diminished capacity to use the glycolysis pathway for ATP generation [113].